rs267607593
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_170707.4(LMNA):c.799T>C(p.Tyr267His) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y267C) has been classified as Uncertain significance.
Frequency
Consequence
NM_170707.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMNA | NM_170707.4 | c.799T>C | p.Tyr267His | missense_variant | Exon 4 of 12 | ENST00000368300.9 | NP_733821.1 | |
LMNA | NM_005572.4 | c.799T>C | p.Tyr267His | missense_variant | Exon 4 of 10 | ENST00000677389.1 | NP_005563.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMNA | ENST00000368300.9 | c.799T>C | p.Tyr267His | missense_variant | Exon 4 of 12 | 1 | NM_170707.4 | ENSP00000357283.4 | ||
LMNA | ENST00000677389.1 | c.799T>C | p.Tyr267His | missense_variant | Exon 4 of 10 | NM_005572.4 | ENSP00000503633.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1Other:1
- -
p.Tyr267His (Y267H) TAT>CAT: c.799 T>C in exon 4 of the LMNA gene (NM_170707.2). The Y267H mutation in the LMNA gene has been reported in association with cardiac conduction disease and DCM (Carboni N et al., 2008; Lakdawala N et al., 2012). Carboni et al. identified Y267H in a woman with atrio-ventricular block and high serum creatine kinase levels, and it was subsequently identified in 5 other relatives with cardiac defects. Y267H was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Mutations in this residue (Y267C) and in nearby residues (L263P, S268P) have been reported in association with laminopathy, further supporting the functional importance of this position and this region of the protein. The variant is found in DCM panel(s). -
Charcot-Marie-Tooth disease type 2 Pathogenic:1
This variant is not present in population databases (gnomAD no frequency). This sequence change replaces tyrosine, which is neutral and polar, with histidine, which is basic and polar, at codon 267 of the LMNA protein (p.Tyr267His). This missense change has been observed in individual(s) with autosomal dominant Emery-Dreifuss muscular dystrophy, cardiac conduction disease and/or dilated cardiomyopathy (PMID: 18337098, 22464770, 22806367, 27532257, 29693488). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 48084). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LMNA protein function. This variant disrupts the p.Tyr267 amino acid residue in LMNA. Other variant(s) that disrupt this residue have been observed in individuals with LMNA-related conditions (PMID: 14684700, 18926329), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
Primary dilated cardiomyopathy Pathogenic:1
The Tyr267His variant has been previously reported in one individual with atrio- ventricular block as well as 5 family members with DCM +/- conduction system def ects (Carboni 2008). The variant was absent from 200 control chromosomes, sugges ting that the variant is disease causing. In addition, tyrosine (Tyr) at positi on 267 is conserved across evolutionary distant species, further supporting a pa thogenic role. In summary, this variant meets our criteria for pathogenicity (ht tp://pcpgm.partners.org/LMM) based upon segregation studies, absence from contro ls and evolutionary conservation of the affected amino acid. -
Cardiovascular phenotype Pathogenic:1
The p.Y267H variant (also known as c.799T>C), located in coding exon 4 of the LMNA gene, results from a T to C substitution at nucleotide position 799. The tyrosine at codon 267 is replaced by histidine, an amino acid with some similar properties. This alteration was shown to segregate with disease in a family with rhythm abnormalities and muscle involvement (Carboni N et al. Neuromuscul. Disord., 2008 Apr;18:291-8). This alteration has also been identified in dilated cardiomyopathy (DCM) cohorts (Lakdawala NK et al. J. Card. Fail., 2012 Apr;18:296-303; Pugh TJ et al. Genet. Med., 2014 Aug;16:601-8). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at